VFEND

VFEND

voriconazole

Manufacturer:

Pfizer
Concise Prescribing Info
Contents
Voriconazole
Indications/Uses
Invasive aspergillosis; candidemia in non-neutropenic patients; serious invasive Candida infections including C. krusei; esophageal candidiasis; serious fungal infections caused by Scedosporium apiospermum & Fusarium sp including Fusarium solani, in patients intolerant of, or refractory to, other therapy.
Dosage/Direction for Use
Tab May be given once the patient can tolerate medication given by mouth. Adult & adolescent (12-16 yr), Patient >40 kg Maintenance dose: 200 mg 12 hrly. Dose may be increased to 300 mg 12 hrly if response is inadequate. Dose may be reduced by 50 mg steps to min of 200 mg 12 hrly if unable to tolerate treatment. Loading dose: 400 mg 12 hrly (for the 1st 24 hr). Patient <40 kg Maintenance dose: 100 mg 12 hrly. Dose may be increased to 150 mg 12 hrly if response is inadequate. Dose may be reduced by 50 mg steps to min of 100 mg 12 hrly if unable to tolerate treatment. Loading dose: 200 mg 12 hrly (for the 1st 24 hr). Childn ≥2 yr Maintenance dose: 200 mg twice daily. Co-administration w/ phenytoin Increase oral maintenance dose to 400 mg 12 hrly in patients >40 kg & 200 mg 12 hrly in patients <40 kg. Vial By IV infusion only. Max rate: 3 mg/kg/hr over 1-2 hr. Initiate treatment w/ a loading dose of 6 mg/kg 12 hrly for 2 doses, followed by a maintenance dose of 4 mg/kg 12 hrly. If patients are unable to tolerate treatment, reduce IV maintenance dose to 3 mg/kg 12 hrly.  Childn Maintenance dose: 7 mg/kg twice daily. If childn are unable to tolerate treatment, reduce IV maintenance dose to 4 mg/kg twice daily. Co-administration w/ phenytoin Increase IV maintenance dose to 5 mg/kg 12 hrly.
Administration
Should be taken on an empty stomach: Take at least 1 hr before or after meals.
Contraindications
Special Precautions
Hypersensitivity to other azoles; patients w/ potentially proarryhthmic conditions; hematological malignancy or other serious underlying medical conditions. Monitor hepatic, pancreatic & renal function & dermatological reactions. Changes to vision. Avoid strong, direct sunlight during therapy. VFEND tab: Avoid use in patients w/ rare hereditary problems of galactose intolerance, Lapp-lactase deficiency or glucose-galactose malabsorption. May impair ability to drive or operate machinery. Pregnancy & lactation. Childn <2 yr.
Adverse Reactions
Visual impairment, fever, chills, headache, abdominal pain, chest pain, tachycardia, HTN or hypotension, vasodilatation, GI disturbances, thrombocytopenia, anemia, leukopenia, pancytopenia, metabolic & nutritional disorders, hallucinations, dizziness, rash, pruritus, maculopapular rash, abnormal kidney function, acute kidney failure.
Drug Interactions
Do not co-administer w/ terfenadine, astemizole, cisapride, pimozide, quinidine, sirolimus, rifampicin, carbamazepine, long-acting barbiturates, rifabutin, ergot alkaloids (ergotamine, dihydroergotamine). Monitor when used w/ cyclosporine, tacrolimus, warfarin & other oral anticoagulants, sulfonylureas, statins, benzodiazepines, vinca alkaloids & Ca-channel blockers, short-acting opiates (CYP3A4 substrates). Dosage adjustments & monitoring required when used w/ phenytoin, omeprazole & other proton pump inhibitors. Monitor for drug toxicity when HIV protease inhibitors or non-nucleoside reverse transcriptase inhibitors are co-administered. St. John's wort.
MIMS Class
Antifungals
ATC Classification
J02AC03 - voriconazole ; Belongs to the class of triazole and tetrazole derivatives. Used in the systemic treatment of mycotic infections.
Presentation/Packing
Form
VFEND FC tab 200 mg
Packing/Price
10's (Rp4,535,445/pak)
Form
VFEND powd for inj 200 mg
Packing/Price
(vial) 1's (Rp1,542,044/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in